6833 — Sinco Pharmaceuticals Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$498.06m
- HK$296.26m
- CNY2.54bn
- 38
- 86
- 24
- 47
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 43 | 136 | 167 | 99.3 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 21.2 | 2.84 | 32.4 | 8.67 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -84 | -10.5 | 99.4 | -44.1 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -9.55 | 137 | 306 | 75.1 | — |
Capital Expenditures | -0.555 | -49.5 | -23.5 | -52.7 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1.99 | 2.64 | 0.795 | -66.6 | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2.54 | -46.8 | -22.7 | -119 | — |
Financing Cash Flow Items | 115 | -62.9 | -304 | 37 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 156 | -170 | -97.1 | 35 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 144 | -81 | 182 | 3.09 | — |